期刊文献+

实施《处方管理办法》对某三级医院处方质量影响 被引量:5

Effects of Prescription Administrative Policy on prescription quality of a tertiary hospital
原文传递
导出
摘要 目的了解《处方管理办法》(以下简称《办法》)的颁布对某三级甲等医院处方质量的影响。方法采用系统随机抽样的方法,抽取该院2007年400例门急诊处方和60名患者,按照《办法》要求,进行处方点评。结果该院处方平均合格率为37.2%。不合格处方主要表现为处方不完整、不规范和不合理等。《办法》实施后,部分指标有显著改善,处方平均合格率提高了12.2%(P=0.004),抗菌药物使用百分率显著降低(P=0.001),药品使用通用名的百分率显著提高(P=0.000)。结论《办法》 Objective To discover the effects of the Prescription Administrative Policy in force on the quality of the prescriptions in a tertiary hospital in 2007. Methods The prescriptions of 400 cases were sampled systematically for evaluation, and 60 patients were interviewed. Results The average eligibility rate of the prescriptions was but 37. 2% in this hospital, which was mainly plagued by incompleteness, nonstandard and irrationality found in prescriptions. Implementation of the Policy contributed to a significant improvement of some indicators. For example, the eligibility rate increased by 12. 2% (P=0. 004), the percentage of the use of antimicrobial agents dropped significantly (P=0. 001), and the percentage of generic names used rose significantly (P = 0. 000). Conclusions The implementation of the Policy is highly positive for prescription quality.
出处 《中华医院管理杂志》 北大核心 2009年第7期463-466,共4页 Chinese Journal of Hospital Administration
关键词 处方 管理 点评制度 合格率 Prescription Administrative Policy System of evaluation Eligibility rate
  • 相关文献

参考文献14

二级参考文献60

共引文献390

同被引文献58

  • 1Bryan F Curtin,Yousef Zarbalian,Mark H Flasar,Erik von Rosenvinge.Clostridium difficile-associated disease:Adherence with current guidelines at a tertiary medical center[J].World Journal of Gastroenterology,2013,19(46):8647-8651. 被引量:1
  • 2严亚明,王浩青,张晓晨,董荣懋,唐扣明,唐桂平,朱江,杨宗英.上海郊区二级医院合理用药国际指标调研[J].药学服务与研究,2005,5(2):122-125. 被引量:45
  • 3张象麟主编.药物临床信息参考[M].成都:四川科学技术出版社,2005.1227.
  • 4WHO/DAP/INRUD. How to investigate drug use in health facilities: selected drug use indicators [M]. Geneva: World Health Orgnization Press, 1993:74.
  • 5Hospital management standard of prescription comment (trial)[J]. 中国药房, 2010, 21(12): 1060-1061.
  • 6GU H Q, WAN Y, LI W. Application of Cochrane collaboration's tool for assessing risk of bias in meta-analysis of randomized controlled trials [J].中国循环杂志, 2014,29(02): 147-148.
  • 7ZHAO R S, ZAI S D. Hospital pharmacy and evidence-based pharmacy[J]. 中国药学杂志, 2007, 42(24): 1922-1924.
  • 8YANG J, LIU M, ZHOU J, et al. Edaravone for acute intracerebral haemorrhage[J]. Cochrane Database Syst Rev, 2011, (2): CD007755.
  • 9WOLF E, MILAZZO S, BOEHM K, et al. Thymic peptides for treatment of cancer patients[J]. Cochrane Database Syst Rev, 2011, (2): CD003993.
  • 10SOOD A, BARTON D L, BAUER B A, et al. A critical review of complementary therapies for cancer-related fatigue[J]. Integr Cancer Ther, 2007, 6(1): 8-13.

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部